BioNano Genomics, Inc. (BNGOU)
BNGOU Price and Sentiment
BNGOU Latest news
Bionano Genomics Would Have Been a Great Find Months Ago
2021-03-02 15:25BNGO stock shot up massively in the past few months. Now isn't the time to invest as the company must first prove its technology sells.
2 Stocks that Ark Invest loves for 2021
2021-02-22 15:05Let's take a look at two companies that Wood has her eye on and has recently added to Ark's large portfolio of funds.
Leverage the Power of Genetics Tech With Bionano Genomics
2021-02-22 14:02BNGO stock is an investment in the future of gene discovery and therapy as Bionano pushes the boundaries of optical genome mapping tech. The post Leverage the Power of Genetics Tech With Bionano Genomics appeared first on InvestorPlace.
Bionano Genomics News: Why BNGO Stock Is Rallying Today
2020-12-30 09:36Bionano Genomics (BNGO) stock is on the move Wednesday with heavy trading following an update from the Nasdaq about its listing status. The post Bionano Genomics News: Why BNGO Stock Is Rallying Today appeared first on InvestorPlace.
Bionano Genomics, Inc. (BNGO) CEO Dr. Erik Holmlin on Q3 2020 Results - Earnings Call Transcript
2020-11-12 18:52Bionano Genomics, Inc. (BNGO) CEO Dr. Erik Holmlin on Q3 2020 Results - Earnings Call Transcript
Bionano Genomics, Inc. (BNGO) Upgraded to Buy: What Does It Mean for the Stock?
2020-10-02 12:00Bionano Genomics, Inc. (BNGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know
2020-08-03 17:50Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $0.79, moving +0.25% from the previous trading session.
What Makes Bionano Genomics, Inc. (BNGO) a New Strong Buy Stock
2020-05-28 12:00Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Bionano Genomics Adds Healthcare and Genomics Industry Experts with Experience in Commercialization and Reimbursement to Its Board of Directors
2020-05-04 17:00Appointments add proven business leadership with strategic knowledge of commercialization of diagnostics to support Bionano’s mission of developing solutions in digital cytogenetics and genomics research Appointments add proven business leadership with strategic knowledge of commercialization of diagnostics to support Bionano’s mission of developing solutions in digital cytogenetics and genomics research
Largest North American Site for FSHD Muscular Dystrophy Testing Adopts Bionano Genomics’ Saphyr for Majority of Clinical Tests
2020-04-22 08:00University of Iowa to use Bionano-based assay to replace most “gold standard” Southern blot tests for molecular diagnosis of FSHD University of Iowa to use Bionano-based assay to replace most “gold standard” Southern blot tests for molecular diagnosis of FSHD